# Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury

> **NCT07016074** · PHASE2 · RECRUITING · sponsor: **University of Michigan** · enrollment: 100 (estimated)

## Conditions studied

- Kidney Injury, Acute

## Interventions

- **DRUG:** Sodium Nitrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07016074
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-30
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07016074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07016074, "Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07016074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*